<DOC>
	<DOCNO>NCT00134394</DOCNO>
	<brief_summary>The study design evaluate efficacy etanercept 50 mg subcutaneously ( SQ ) weekly plus tacrolimus 0.1 % topical ointment twice daily compare etanercept 50 mg SQ weekly plus placebo ointment twice daily .</brief_summary>
	<brief_title>Etanercept With Tacrolimus Psoriasis</brief_title>
	<detailed_description>The study design evaluate efficacy etanercept 50 mg SQ weekly plus tacrolimus 0.1 % topical ointment twice daily compare etanercept 50 mg SQ weekly plus placebo ointment twice daily . Subjects either begin etanercept therapy already use stable dose etanercept begin apply tacrolimus half body placebo ointment half . The study double blind . Total duration study 12 week .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Inclusion Criteria Adults 18 year old moderate severe psoriasis , candidate systemic phototherapy , baseline score 6 high target lesion score , baseline score 3 high Physician 's Global Assessment , side body Patients already stable dose etanercept least 2 month criteria Subjects must target lesion side body least 1.5 cm diameter roughly symmetrical appearance location Exclusion Criteria Inability understand consent comply study requirement Pregnancy unwillingness use adequate birth control method Lactation Psoriasis plus ultraviolet A ( PUVA ) systemic therapy within past 4 week ( stable dose Enbrel least 2 month ) Ultraviolet B ( UVB ) topical therapy ( overthecounter moisturizers ) within past 2 week Active tuberculosis opportunistic infection Demyelinating disease Uncontrolled congestive heart failure Known allergy contraindication use topical tacrolimus etanercept Lack insurance coverage inability/refusal pay pocket etanercept standard care laboratory test PPD/CXR</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>etanercept</keyword>
</DOC>